Concord's Datong Meizhongjiahe Cancer Hospital preliminarily opens in China
Concord Medical Services has announced the preliminary opening of Datong Meizhongjiahe Cancer Hospital in China.
The100-bed hospital houses advanced radiotherapy and diagnostic imaging equipment such as linear accelerator and MRI.
This registered Level-II speciality cancer hospital offers radiation, imaging, laboratory testing, inpatient, and nursing services.
Concord Medical chairman and CEO Dr. Jianyu Yang said: "This first wholly-owned domestic cancer hospital in China is an important step of our broad strategy to build a nationwide chain of free-standing cancer treatment and diagnosis centres under the brand "Meizhongjiahe" in the future.
"Currently, the healthcare reform has touched upon many historically challenging issues, such as multi-location practice for doctors and equipment licensing to private hospitals. We will capitalize on this growing opportunity and rely on our excellent doctor resources as well as strong medical network to contribute to the improvement of overall level of cancer treatment and diagnosis in China, generating long-term and stable returns for our shareholders."
Currently, Concord is working on the establishment of speciality cancer hospitals in cities such as Wuxi, Hangzhou, Taizhou, and Nanchang, as it seeks to expand in the domestic market.
Through its Meizhongjiahe network, the company will provide advanced, best-practice diagnostic and treatments for patients in Tier II and Tier III cities.